We are live on ! Find out more
LOXO

Loxo Oncology, Inc
LOXO

Delisted

LOXO was delisted on the 14th of February, 2019.

Back to rankings

129 hedge funds and large institutions have $2.4B invested in Loxo Oncology, Inc in 2017 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 49 increasing their positions, 24 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,075% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 4

267% more funds holding in top 10

Funds holding in top 10: 3 → 11 (+8)

113% more capital invested

Capital invested by funds: $1.12B → $2.4B (+$1.27B)

104% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 24

50% more funds holding

Funds holding: 86 → 129 (+43)

63% less call options, than puts

Call options by funds: $2.09M | Put options by funds: $5.7M

Holders
129
Holders Change
+43
Holders Change %
+50%
% of All Funds
3.22%
Holding in Top 10
11
Holding in Top 10 Change
+8
Holding in Top 10 Change %
+266.67%
% of All Funds
0.27%
New
47
Increased
49
Reduced
24
Closed
4
Calls
$2.09M
Puts
$5.7M
Net Calls
-$3.62M
Net Calls Change
-$3.62M

Top Buyers

Rank Fund Capital Flow
1
O
OppenheimerFunds
New York
+$36.5M
2
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$32.3M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$26.2M
4
MWNA
Marshall Wace North America
New York
+$23.1M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$20.7M

Top Sellers

Rank Fund Capital Flow
1
Victory Capital Management
Victory Capital Management
Texas
-$29.5M
2
DM
Deerfield Management
New York
-$27.8M
3
Franklin Resources
Franklin Resources
California
-$13.9M
4
DCM
Driehaus Capital Management
Illinois
-$13.4M
5
RCM
RA Capital Management
Massachusetts
-$12.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
AA
76
ALPS Advisors
Colorado
$1.89M +$89.9K +1,623 +7%
RhumbLine Advisers
77
RhumbLine Advisers
Massachusetts
$1.81M +$291K +5,260 +30%
Two Sigma Investments
78
Two Sigma Investments
New York
$1.77M +$1.22M +22,052 New
SIM
79
Spark Investment Management
New York
$1.69M +$1.17M +21,100 New
AR
80
Advisory Research
Illinois
$1.66M -$205K -3,698 -15%
SGH
81
Sivik Global Healthcare
Connecticut
$1.64M +$1.14M +20,500 New
DekaBank Deutsche Girozentrale
82
DekaBank Deutsche Girozentrale
Germany
$1.59M – – –
GA
83
Geneva Advisors
Illinois
$1.55M +$1.07M +19,345 New
AQR Capital Management
84
AQR Capital Management
Connecticut
$1.31M +$459K +8,280 +102%
Wells Fargo
85
Wells Fargo
California
$1.29M +$32.8K +592 +4%
Manulife (Manufacturers Life Insurance)
86
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.25M +$241K +4,357 +39%
ProShare Advisors
87
ProShare Advisors
Maryland
$1.22M +$97.9K +1,767 +13%
MIM
88
Monashee Investment Management
Massachusetts
$1.2M +$831K +15,000 New
Neuberger Berman Group
89
Neuberger Berman Group
New York
$1.2M +$831K +15,000 New
GAMA
90
Graticule Asia Macro Advisors
New York
$1.12M +$776K +14,000 New
State of Wisconsin Investment Board
91
State of Wisconsin Investment Board
Wisconsin
$1.12M +$776K +14,000 New
OPPM
92
Opus Point Partners Management
New York
$1.11M +$765K +13,800 New
MLICM
93
Metropolitan Life Insurance Company (MetLife)
New York
$1.09M +$172K +3,097 +29%
SCM
94
Suffolk Capital Management
New York
$1.04M +$718K +12,958 New
AIG
95
American International Group
New York
$996K +$148K +2,672 +27%
WMSA
96
Weiss Multi-Strategy Advisers
New York
$922K +$637K +11,500 New
Tudor Investment Corp
97
Tudor Investment Corp
Connecticut
$837K +$579K +10,442 New
TD Asset Management
98
TD Asset Management
Ontario, Canada
$779K +$538K +9,710 New
Citigroup
99
Citigroup
New York
$670K -$196K -3,543 -30%
State Board of Administration of Florida Retirement System
100
State Board of Administration of Florida Retirement System
Florida
$670K +$463K +8,360 New
2 3
4
5 6

LOXO Hedge Fund Activity: Q2 2017 in Review

129 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Loxo Oncology, Inc (LOXO) for Q2 2017, worth a combined $2.4B — up 113% from $1.12B a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new LOXO positions and 4 closed out — a net gain of 43 holders — while 49 added to existing stakes and 24 trimmed.

The largest buyer was OppenheimerFunds, opening a new position worth an estimated $36.5M. The largest seller was Victory Capital Management, cutting an estimated $29.5M.

  • 129 institutional investors held Loxo Oncology, Inc (LOXO) as of Q2 2017, up from 86 in Q1 2017.
  • Funds reported $2.4B of Loxo Oncology, Inc stock for Q2 2017, up 113% quarter-over-quarter.
  • 47 funds opened new Loxo Oncology, Inc positions in Q2 2017 and 4 closed out, a net change of +43 holders.
  • The largest Loxo Oncology, Inc buyer in Q2 2017 was OppenheimerFunds, an estimated $36.5M added.
  • The largest Loxo Oncology, Inc seller in Q2 2017 was Victory Capital Management, an estimated $29.5M sold.

Based on aggregated 13F filings for Q2 2017.